2,3-Dimethoxyaniline → 1-(Tert-butoxycarbonyl)-4-(2,3-dimethoxyphenylamino)piperidine

HRID 984259Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 984259
[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][C:11](=O)[CH2:10][CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].[CH3:15][O:16][C:17]1[C:23]([O:24][CH3:25])=[CH:22][CH:21]=[CH:20][C:18]=1[NH2:19]>>[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH:11]([NH:19][C:18]2[CH:20]=[CH:21][CH:22]=[C:23]([O:24][CH3:25])[C:17]=2[O:16][CH3:15])[CH2:10][CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2]

Komponenten

3

Versuchsvorschrift

1-(tert-Butoxycarbonyl)-4-piperidone (4.78 g) and 2,3-dimethoxyaniline (3.68 g) were condensed in the same manner as described in Preparation Example 37 to give the title compound.

Aufarbeitung

  1. customcondensed in the same manner
  2. customas described in Preparation Example 37

Quellen und Nachweise

ORD-Eintrag
ord-d1a348f00c284cf1930ee691bfe67903
Quelldatensatz
uspto-grants-2005_03
Patentnummer
US06867221B2

Notizen zur Reaktion

Wird geladen…